Business ContextStrengthening commercial leadership ahead of fundraising and pharmaceutical partnerships
The company had developed an AI platform capable of identifying novel therapeutic targets and was generating promising scientific data. As discussions with investors gathered pace, attention turned from validating the science to demonstrating commercial potential.
Alongside fundraising, the business needed to establish strategic partnerships with pharmaceutical companies and create a clear route to future revenue.






